This inventor holds 3 USPTO granted patents. Top assignees: Endorfin, Inc., Other. Active years: 1984-1987.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1984-1987
Title: Reuben C Balagot: Innovator in Analgesic and Anti-Inflammatory Compositions
Introduction
Reuben C Balagot is a notable inventor based in Chicago, IL (US). He has made significant contributions to the field of analgesic and anti-inflammatory compositions. With a total of 3 patents to his name, Balagot's work has the potential to impact therapeutic practices significantly.
Latest Patents
Balagot's latest patents focus on innovative analgesic and anti-inflammatory compositions. One of his patents describes compositions that include a therapeutically effective amount of hydrocinnamic acid, either alone or in combination with specific amino acids such as D-phenylalanine, DL-phenylalanine, D-leucine, and DL-leucine. These compositions also incorporate a synergistically effective amount of a second therapeutic agent, which can be aspirin or an aspirin-type non-steroidal anti-inflammatory, anti-pyretic agent. Another patent similarly outlines compositions that utilize a first agent from the same group of amino acids, combined with a second therapeutic agent from the aspirin category.
Career Highlights
Throughout his career, Balagot has worked with various companies, including Endorfin, Inc. His innovative approach to developing analgesic and anti-inflammatory solutions has positioned him as a key figure in this area of research.
Collaborations
Balagot has collaborated with notable individuals in his field, including Seymour Ehrenpreis and Joseph E Comaty. These partnerships have likely contributed to the advancement of his research and patent developments.
Conclusion
Reuben C Balagot's contributions to analgesic and anti-inflammatory compositions highlight his innovative spirit and dedication to improving therapeutic options. His patents reflect a commitment to advancing medical science and enhancing patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile